A detailed history of Trinity Legacy Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Trinity Legacy Partners, LLC holds 15,143 shares of AMGN stock, worth $4.78 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
15,143
Previous 15,056 0.58%
Holding current value
$4.78 Million
Previous $4.28 Million 10.54%
% of portfolio
1.35%
Previous 1.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $22,859 - $27,779
87 Added 0.58%
15,143 $4.73 Million
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $615,443 - $742,917
2,289 Added 17.93%
15,056 $4.28 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $9,205 - $10,384
36 Added 0.28%
12,767 $3.68 Million
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $2.78 Million - $3.46 Million
12,731 New
12,731 $3.42 Million
Q4 2021

Jan 13, 2022

BUY
$198.88 - $227.6 $227,319 - $260,146
1,143 New
1,143 $257,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Trinity Legacy Partners, LLC Portfolio

Follow Trinity Legacy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Legacy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Legacy Partners, LLC with notifications on news.